ACST

Acasti Pharma (ACST)

Acasti Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ACST

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/11	05:11	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ACST	Acasti Pharma Inc
2024/05/11	05:07	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ACST	Acasti Pharma Inc
2024/05/09	08:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2024/05/09	08:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2024/05/09	08:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2024/05/09	08:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2024/05/09	08:18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2024/02/12	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACST	Acasti Pharma Inc
2024/02/12	21:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACST	Acasti Pharma Inc
2024/01/08	22:00	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2024/01/08	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACST	Acasti Pharma Inc
2023/12/21	06:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2023/12/21	06:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2023/12/21	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2023/12/15	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACST	Acasti Pharma Inc
2023/11/13	21:30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ACST	Acasti Pharma Inc
2023/10/24	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACST	Acasti Pharma Inc
2023/10/21	01:23	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2023/10/17	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ACST	Acasti Pharma Inc
2023/10/17	05:31	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ACST	Acasti Pharma Inc
2023/10/12	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACST	Acasti Pharma Inc
2023/10/10	20:40	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:ACST	Acasti Pharma Inc
2023/10/07	05:30	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ACST	Acasti Pharma Inc
2023/09/28	08:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2023/09/26	21:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACST	Acasti Pharma Inc
2023/09/06	04:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ACST	Acasti Pharma Inc
2023/08/26	06:01	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ACST	Acasti Pharma Inc
2023/08/26	05:21	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ACST	Acasti Pharma Inc
2023/08/26	05:15	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ACST	Acasti Pharma Inc
2023/08/11	20:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ACST	Acasti Pharma Inc